Non-destructive Molecular Imaging for Bone Microenvironment Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for imaging cells within the bone environment, such as micro-CT or ultrasound, face limitations in resolution at the cellular level due to the surrounding physiological environment, making it difficult to study intracellular dynamics and protein expression of cells embedded within mineralized bone tissue without sample manipulation.
Innovation Solution
A non-destructive molecular imaging method using microfluidic devices with bisphosphonate imaging agents, such as pamidronate with a fluorescent label, and radiolabels like technetium-99m, combined with imaging techniques like Micro CT, Micro SPECT, and PET, to monitor cellular mineralization and secreted extracellular macromolecules without harvesting the tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional imaging methods like micro-CT or ultrasound are used to image cells within bone, then bone structure can be visualized, but resolution at the cellular level deteriorates due to the surrounding physiological environment
Solution Approach 1:
The patent extracts cells from the complex bone physiological environment by using organotypic culture systems that separate cells into controlled culture conditions. This allows imaging of cellular processes without the interfering physiological environment of intact bone, while still maintaining cell-bone matrix interactions through cultured bone slices or organotypic cultures.
Solution Approach 2:
The patent introduces molecular imaging agents as intermediaries that specifically target cellular components of interest. These agents (such as fluorescently labeled antibodies, peptides, or small molecules) bind to specific proteins or structures within cells, enabling high-resolution imaging of cellular processes without being affected by the surrounding physiological environment.
2Measurement precision
If sample manipulation is performed to prepare bone tissue for imaging, then cellular structures can be visualized, but biochemical properties of antigenicity and mineral structure deteriorate
Solution Approach 1:
The patent replaces mechanical and chemical sample preparation methods (sectioning, staining, fixation) with non-destructive molecular imaging techniques. Live-cell imaging, confocal microscopy, and molecular probes allow visualization of cellular structures in intact, living bone tissue without disrupting biochemical properties or requiring sample manipulation.
Solution Approach 2:
The patent employs self-labeling techniques where cells or tissue components naturally express or bind imaging agents without external manipulation. For example, using genetically encoded fluorescent proteins that cells produce themselves, or molecular probes that automatically bind to target structures, eliminating the need for destructive preparation while maintaining biochemical integrity.
3Loss of information
If destructive methods are used to harvest tissue for analysis, then intracellular dynamics can be studied, but the tissue structure and living state deteriorate
Solution Approach 1:
The patent enables continuous, long-term imaging of intracellular dynamics in living bone tissue through organotypic culture systems. Cells can be monitored over days or weeks in their native bone matrix environment without harvesting, allowing observation of dynamic processes like cell migration, differentiation, and matrix remodeling while maintaining tissue integrity and physiological relevance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables quantitative monitoring of specific biological processes over time within the bone microenvironment, providing valuable data on cellular dynamics and response to agents without disrupting the tissue, thereby improving the understanding of bone development and function.
Implementation Method 1
the labeling agent is capable of binding to cellular mineralization
Implementation Method 2
pamidronate with a fluorescent label
Implementation Method 3
radiolabels like technetium-99m
Implementation Method 4
imaging techniques like Micro CT, Micro SPECT, and PET
Data Source
AI summary
Microfluidic “organ-on-a-chip” devices have been developed with the aim to replicate human tissues in vitro. However, there is no option to quantitatively monitor biological processes that take place within the chip, over time. Destructive methods in order to analyze, tissue formation, gene expression, protein secretion etc. require the harvest of the “tissue” at a certain time point. Described herein are methods and compositions for non-destructive molecular imaging methods and systems in order to quantitatively monitor specific biological processes, over time, within the chip, without the need to harvest.